BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2427188)

  • 1. Susceptibility to NK cell lysis is abolished in tumor cells by a factor which restores their contact inhibited growth.
    Nabi ZF; Zucker-Franklin D; Lipkin G; Rosenberg M
    Cancer; 1986 Oct; 58(7):1461-5. PubMed ID: 2427188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells.
    Jarahian M; Watzl C; Issa Y; Altevogt P; Momburg F
    Int J Cancer; 2007 Jun; 120(12):2625-34. PubMed ID: 17294447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interferons on the inhibition of human natural killers by primary monolayer cell cultures.
    Heiskala M
    Immunology; 1987 Feb; 60(2):167-72. PubMed ID: 2434416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K; Tilden AB; Balch CM
    J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of differentiation inducers on the sensitivity of two myeloid cell lines to natural killer (NK) cell-mediated lysis.
    Golden M; Dempsey RA; Mier JW; Parkinson DR
    Int J Immunopharmacol; 1983; 5(5):411-9. PubMed ID: 6197382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
    Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
    J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
    Ma D; Niederkorn JY
    Immunology; 1995 Oct; 86(2):263-9. PubMed ID: 7490128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC; Bonavida B
    J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
    Losinno C; Wines BD; Johns TG; Mackay IR
    Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
    Menier C; Riteau B; Carosella ED; Rouas-Freiss N
    Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
    Bridges KR; Smith BR
    J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells.
    Repp AC; Mayhew ES; Apte S; Niederkorn JY
    J Immunol; 2000 Jul; 165(2):710-5. PubMed ID: 10878343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.
    Markel G; Lieberman N; Katz G; Arnon TI; Lotem M; Drize O; Blumberg RS; Bar-Haim E; Mader R; Eisenbach L; Mandelboim O
    J Immunol; 2002 Mar; 168(6):2803-10. PubMed ID: 11884449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
    Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A
    Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.